(Q46088222)

19 December 2017

title

What have we learnt from mouse models for the study of malaria? (English)

1 reference

19 December 2017

0 references

1

1 reference

19 December 2017

Michael F. Good

series ordinal

2

object named as

Michael F Good

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

19 December 2017

European Journal of Immunology

published in

1 reference

19 December 2017

volume

39

1 reference

19 December 2017

issue

8

1 reference

19 December 2017

page(s)

2004-2007

1 reference

19 December 2017

Apoptotic deletion of Th cells specific for the 19-kDa carboxyl-terminal fragment of merozoite surface protein 1 during malaria infection

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

Innate immune response to malaria: rapid induction of IFN-gamma from human NK cells by live Plasmodium falciparum-infected erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

Systemic tumor necrosis factor generated during lethal Plasmodium infections impairs dendritic cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

Dendritic cells from malaria-infected mice are fully functional APC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

Cutting edge: conventional dendritic cells are the critical APC required for the induction of experimental cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

Plasmodium yoelii can ablate vaccine-induced long-term protection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

A case for whole-parasite malaria vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Immunological processes in malaria pathogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Deletion of Plasmodium berghei-specific CD4+ T cells adoptively transferred into recipient mice after challenge with homologous parasite

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

The mechanism and significance of deletion of parasite-specific CD4(+) T cells in malaria infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Cross-talk with myeloid accessory cells regulates human natural killer cell interferon-gamma responses to malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

gammadelta-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-gamma response to Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Splenic gammadelta T cells regulated by CD4+ T cells are required to control chronic Plasmodium chabaudi malaria in the B-cell-deficient mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

What really happens to dendritic cells during malaria?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Response of the splenic dendritic cell population to malaria infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Plasmodium strain determines dendritic cell function essential for survival from malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Malaria infection changes the ability of splenic dendritic cell populations to stimulate antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Malaria blood stage suppression of liver stage immunity by dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

A role for CD36 in the regulation of dendritic cell function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Immunity to malaria: more questions than answers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Anti-malaria antibody-producing B cell frequencies in adults after a Plasmodium falciparum outbreak in Madagascar.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Immunity to Plasmodium chabaudi adami in the B-cell-deficient mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Protection of rats against malaria by a transplanted immune spleen.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

The role of CD4+ T cells in the protective immune response to Plasmodium chabaudi in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Towards a blood-stage vaccine for malaria: are we following all the leads?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Macrophage-mediated but gamma interferon-independent innate immune responses control the primary wave of Plasmodium yoelii parasitemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Stimulation of innate immune responses by malarial glycosylphosphatidylinositol via pattern recognition receptors.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Murine cerebral malaria development is independent of toll-like receptor signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Pathological role of Toll-like receptor signaling in cerebral malaria.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Bone marrow chimeric mice reveal a dual role for CD36 in Plasmodium berghei ANKA infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Liver-stage development of Plasmodium falciparum, in a humanized mouse model

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Selection of a trioxaquine as an antimalarial drug candidate

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Plasmodium falciparum-infected mice: more than a tour de force

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Increased parasitaemia and delayed parasite clearance in Schistosoma mansoni and Plasmodium berghei co-infected mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Exacerbation of Plasmodium yoelii malaria in Echinostoma caproni infected mice and abatement through anthelmintic treatment.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Plasmodium yoelii: adverse outcome of non-lethal P. yoelii malaria during co-infection with Schistosoma mansoni in BALB/c mouse model

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Reduced protective efficacy of a blood-stage malaria vaccine by concurrent nematode infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939552

7 January 2021

Identifiers

DOI

10.1002/EJI.200939552

1 reference

19 December 2017

release_247cdmzrdvgs3lgauxzrp7scmy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/247cdmzrdvgs3lgauxzrp7scmy

24 November 2022

mapped directly with Wikidata item

PubMed ID

19672886

1 reference

19 December 2017